COM:ISOPLEXIS
Bruker Cellular Analysis
- Stock
Last Close
0.76
20/03 20:00
Market Cap
30.28M
Beta: -
Volume Today
111.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | 3.57M - | 14.13M 295.27% | 25.91M 83.39% | ||
average payables | 1.81M - | 3.49M 92.97% | 3.81M 9.25% | ||
average receivables | 2.88M - | 3.51M 21.74% | 4.30M 22.50% | ||
book value per share | 0.90 - | 2.37 163.08% | 13.89 485.19% | 1.05 92.44% | |
capex per share | -0.06 - | -0.06 5.37% | -2.37 3,903.85% | -0.20 91.60% | |
capex to depreciation | -4.37 - | -2.61 40.30% | -10.50 302.15% | -1.58 84.99% | |
capex to operating cash flow | 0.15 - | 0.10 29.74% | 0.28 173.72% | 0.08 71.12% | |
capex to revenue | -0.29 - | -0.22 23.86% | -1.40 535.25% | -0.47 66.78% | |
cash per share | 0.70 - | 2.75 289.61% | 12.36 350.22% | 0.95 92.29% | |
days of inventory on hand | 357.72 - | 290.22 18.87% | 1.04K 259.86% | 567.87 45.63% | |
days payables outstanding | 165.58 - | 156.82 5.29% | 207.99 32.63% | 57.41 72.40% | |
days sales outstanding | 138.41 - | 102.68 25.82% | 86.71 15.55% | 98.04 13.06% | |
debt to assets | 0.07 - | 0.25 239.32% | 0.24 5.02% | 0.62 157.68% | |
debt to equity | 0.08 - | 0.34 320.81% | 0.32 6.62% | 1.64 416.74% | |
dividend yield | 1.63 - | ||||
earnings yield | -0.03 - | -0.05 71.23% | -0.06 8.50% | -1.90 3,247.70% | |
enterprise value | 420.11M - | 362.98M 13.60% | -815.60K 100.22% | 75.16M 9,314.82% | |
enterprise value over ebitda | -32.03 - | -16.29 49.13% | 0.01 100.07% | -0.82 7,714.41% | |
ev to operating cash flow | -28.09 - | -16.18 42.39% | 0.01 100.06% | -0.78 8,348.45% | |
ev to sales | 55.98 - | 34.95 37.57% | -0.05 100.14% | 4.48 9,588.06% | |
free cash flow per share | -0.44 - | -0.64 44.31% | -10.81 1,598.60% | -2.66 75.43% | |
free cash flow yield | -0.04 - | -0.06 44.31% | -1.18 2,029.26% | -1.71 45.66% | |
graham net net | 0.73 - | 2.04 180.95% | 9.43 361.26% | -0.34 103.56% | |
graham number | 2.67 - | 5.67 112.24% | 12.75 125.06% | 8.33 34.68% | |
income quality | 1.10 - | 0.96 12.15% | 1.06 9.98% | 0.91 14.03% | |
intangibles to total assets | 0.02 - | 0.01 46.08% | 0.11 743.04% | 0.18 62.20% | |
interest coverage | -13.62K - | -1.10K 91.90% | -21.10 98.09% | -18.95 10.17% | |
interest debt per share | 0.00 - | 0.57 2,215,700% | 3.44 503.72% | 1.45 57.89% | |
inventory turnover | 1.02 - | 1.26 23.26% | 0.35 72.21% | 0.64 83.92% | |
invested capital | 0.24 - | 0.22 7.33% | 1.25 462.89% | ||
market cap | 447.49M - | 447.49M 0% | 94.10M 78.97% | 60.94M 35.24% | |
net current asset value | 31.03M - | 84.28M 171.57% | 113.22M 34.34% | 4.06M 96.41% | |
net debt to ebitda | 2.09 - | 3.79 81.77% | 1.25 66.92% | -0.16 112.37% | |
net income per share | -0.35 - | -0.60 71.23% | -0.52 13.44% | -2.94 464.63% | |
operating cash flow per share | -0.39 - | -0.58 49.98% | -8.45 1,362.77% | -2.46 70.91% | |
payables turnover | 2.20 - | 2.33 5.59% | 1.75 24.60% | 6.36 262.26% | |
receivables turnover | 2.64 - | 3.55 34.80% | 4.21 18.41% | 3.72 11.55% | |
research and ddevelopement to revenue | 1.35 - | 1.07 20.45% | 1.21 13.10% | 1.40 15.43% | |
return on tangible assets | -0.37 - | -0.19 48.12% | -0.03 83.28% | -1.29 3,943.95% | |
revenue per share | 0.19 - | 0.27 38.40% | 1.69 530.28% | 0.43 74.71% | |
roe | -0.39 - | -0.25 34.91% | -0.04 85.21% | -2.80 7,373.06% | |
roic | 0.74 - | 0.25 65.93% | 0.07 72.07% | -3.52 5,075.21% | |
sales general and administrative to revenue | 0.64 - | 0.77 20.62% | 1.53 97.66% | 2.55 66.78% | |
shareholders equity per share | 0.90 - | 2.37 163.08% | 13.89 485.19% | 1.05 92.44% | |
stock based compensation to revenue | 0.02 - | 0.05 161.23% | 0.12 142.49% | 0.26 117.20% | |
tangible asset value | 34.12M - | 90.57M 165.46% | 121.24M 33.87% | 21.44M 82.31% | |
tangible book value per share | 0.88 - | 2.33 165.46% | 11.84 407.81% | 0.55 95.39% | |
working capital | 31.16M - | 111.05M 256.44% | 144.86M 30.45% | 54.15M 62.62% |
All numbers in (except ratios and percentages)